Polaris AI Pharma (XKRX:041910) Interest Expense : ₩-23 Mil (TTM As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Polaris AI Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Polaris AI Pharma's interest expense for the three months ended in Dec. 2024 was ₩ -9 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-23 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Polaris AI Pharma's Operating Income for the three months ended in Dec. 2024 was ₩ -1,099 Mil. Polaris AI Pharma's Interest Expense for the three months ended in Dec. 2024 was ₩ -9 Mil. Polaris AI Pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Polaris AI Pharma Interest Expense Historical Data

The historical data trend for Polaris AI Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris AI Pharma Interest Expense Chart

Polaris AI Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-11.20

-6.28

-29.64

-38.28

-22.53

Polaris AI Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-14.28	-8.63	-8.20	3.78	-9.47

Polaris AI Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-23 Mil.

Polaris AI Pharma (XKRX:041910) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Polaris AI Pharma's Interest Expense for the three months ended in Dec. 2024 was ₩-9 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩-1,099 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩588 Mil.

Polaris AI Pharma's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Polaris AI Pharma did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Polaris AI Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

25 Balangongdan-ro, Hyangnam-eup, Gyeonggi-do, Hwaseong-si, KOR

Website

https://www.polarisaipharma.com

Polaris AI Pharma Corp is engaged in the production of raw pharmaceutical ingredients. It focuses on generic drugs and produces about 40 types of raw medicines, including asthma treatments, gastric ulcer treatments, and alcohol dependence treatments, and supplies them domestically and internationally.

Polaris AI Pharma Headlines

No Headlines